Trevi Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Trevi Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Trevi Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Trevi Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $538k | 59k | 9.15 |
| 2025-03-31 | $399k | 64k | 6.29 |
| 2024-12-31 | $913k | 222k | 4.12 |
| 2024-09-30 | $336k | 101k | 3.34 |
| 2024-06-30 | $93k | 31k | 2.98 |
| 2024-03-31 | $88k | 26k | 3.45 |
| 2023-12-31 | $36k | 27k | 1.34 |
| 2023-09-30 | $59k | 27k | 2.18 |
| 2023-06-30 | $79k | 33k | 2.39 |
| 2020-09-30 | $0 | 3 | 0.00 |
| 2020-06-30 | $0 | 3 | 0.00 |